Comprehensive Gene Therapy Testing Services for Safe and Compliant Therapeutics
Trusted by global biopharma leaders for viral vector testing, biosafety, identity, potency, and purity assessments — all aligned with FDA and EMA requirements.
We have a proven track record of supporting clients in their race to market and providing value through:
✅ Viral Vector Testing & Analysis — including AAV, lentiviral, retroviral vectors
✅ Biosafety Testing — ensuring safety from adventitious agents and replication-competent viruses
✅ Gene Therapy Identity Testing — confirm product integrity and regulatory compliance
✅ Potency & Purity Testing — critical analysis for therapeutic efficacy and purity
✅ Characterization & Quality Support — full product profiling and CMC support
✅ Manufacturing & IND Support — analytical method validation and GMP testing
✅ Global Lab Network — strategically located facilities in North America with rapid turnaround
✅ Regulatory Expertise — aligned with FDA, EMA, WHO, and ICH guidelines
SGS provides end-to-end Gene Therapy Testing Services to support product development, manufacturing, and regulatory submissions in the USA and Canada. From vector testing to gene therapy biosafety testing, we help you bring safe and effective therapies to market — faster.
SGS’s long history and expertise in biopharmaceutical testing, wide geographical footprint and superior client service support combine to provide an outstanding partner for your Cell and Gene Therapy outsourcing needs.
SGS has an expansive global network of laboratories, including 5 GMP facilities in North America, offering a broad portfolio of CMC testing solutions and scientific expertise with the highest quality standards under global GMP compliance.
With one of the most comprehensive analytical support packages for the manufacture of cell and gene therapy products, SGS provides access to an exceptional testing portfolio and expertise found within our key biopharmaceutical pillars of biosafety, characterization and QC & release.